Najlepsi lekarze w zakresie leczenia raka wątroby stadium 4 za granicą — Strona 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr Alexander Beny kieruje oddziałem nowotworów układu pokarmowego w Rambam Medical Center, specjalizując się w zaawansowanych przypadkach raka wątroby.

• Certyfikowany onkolog z szerokim doświadczeniem w onkologii klinicznej i radioterapii
• Dyrektor usług onkologii układu pokarmowego w dużym izraelskim szpitalu
• Ukończył specjalistyczne szkolenie z nowoczesnych technik brachyterapii
• Biegle włada językiem angielskim i hebrajskim, co ułatwia komunikację z pacjentami międzynarodowymi

Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.

He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.

Specjalizuje się w złożonych operacjach onkologicznych, w tym zabiegach w obrębie wątroby, trzustki i dróg żółciowych w szpitalach Büyük Anadolu.

• Ekspert w chirurgii onkologicznej ze szczególnym uwzględnieniem nowotworów przewodu pokarmowego
• Wykonuje zaawansowane operacje bariatryczne i metaboliczne
• Doświadczony w operacjach raka piersi i tarczycy

Dr Brenda Pastrana jest certyfikowanym chirurgiem onkologicznym specjalizującym się w raku wątroby w szpitalu Galenia.

• Członek Meksykańskiego Towarzystwa Onkologicznego
• Wykładowca uniwersytecki na Universidad Anahuac od 2020 roku
• Tytuł uzyskany na Narodowym Uniwersytecie Autonomicznym Meksyku (UNAM)
• Wyszkolona jako chirurg onkolog w Centro Medico Nacional 20 de Noviembre

Prof. Elke Jaeger to czołowa onkolog w Niemczech z 41 lat doświadczenia doświadczeniem, specjalizująca się w zaawansowanym raku wątroby w klinice Nordwest.

• Kierownik Oddziału Onkologii i Hematologii w klinice Nordwest
• Przeprowadziła ponad 1100 zabiegów onkologicznych
• Wymieniana wśród najlepszych onkologów w Niemczech od 41 lat doświadczenia
• Profesor onkologii medycznej i hematologii
• Członek Europejskiej Organizacji Badań i Leczenia Raka (EORTC)

Dr Topcu odbyła szkolenie w MD Anderson Cancer Center i specjalizuje się w raku wątroby oraz innych dziedzinach onkologii. Wnosi bogate międzynarodowe doświadczenie do swojej praktyki w Szpitalu Uniwersyteckim Biruni.

• Certyfikowany onkolog kliniczny z ponad _doctor_9372_ letnim doświadczeniem
• Członek Europejskiego Towarzystwa Onkologii Klinicznej (ESMO)
• Szkoliła się w wiodących ośrodkach onkologicznych w USA i Kanadzie
• Specjalizuje się w złożonych nowotworach przewodu pokarmowego, w tym raku wątroby

Dr Atakan Topcu jest onkologiem klinicznym w szpitalu Medipol Acibadem District w Stambule. Specjalizuje się w leczeniu guzów litych, w tym raka płuc, piersi oraz raka jelita grubego. Dr Topcu jest profesorem nadzwyczajnym i autorem ponad 50 recenzowanych publikacji naukowych. Zasiada w radzie redakcyjnej czasopisma medycznego BMC Cancer.

• Ekspertyza w zakresie immunoterapii, terapii celowanych oraz onkologii geriatrycznej.
• Leczenie niedożywienia nowotworowego, kacheksji i sarkopenii.
• Aktywny członek Europejskiego Towarzystwa Onkologii Klinicznej (ESMO).
• Pracuje w szpitalu z akredytacją JCI, specjalizującym się w zaawansowanych metodach leczenia onkologicznego.

Profesor Gul Alco specjalizuje się w onkologii radiacyjnej w szpitalu Medipol Acibadem, posiadając ponad _doctor_7679_lat_ doświadczenia w tej dziedzinie.

• Profesor na Wydziale Onkologii Radiacyjnej Uniwersytetu Medipol w Stambule
• Ukończyła rezydenturę w Szkole Medycznej Uniwersytetu Kadir Has
• Docent, a następnie profesor na Uniwersytecie Demiroglu Bilim
• Pracowała w szpitalu Şişli Florence Nightingale oraz szpitalu Gayrettepe Florence Nightingale

Dr Ayşe İrem Yasin jest onkologiem medycznym w szpitalu Medipol Acıbadem w Stambule. Posiada prestiżowy certyfikat ESMO. Dr Yasin specjalizuje się w nowotworach litych, w tym raku piersi, płuc i przewodu pokarmowego. Leczy złożone przypadki, takie jak rak z komórek Merkla oraz nowotwory o nieznanym punkcie wyjścia.

• Szkoliła się w Harvard Medical School, Cleveland Clinic oraz Szpitalu Uniwersyteckim w Bazylei.
• Ukończyła staż kliniczny w jednostce raka piersi w Novarze we Włoszech.
• Leczy nowotwory mózgu i OUN, mięsaki tkanek miękkich oraz nowotwory układu moczowego.
• Pracuje w placówce akredytowanej przez JCI, wyposażonej w system robotyczny da Vinci.

Nail Paksoy wnosi bogate doświadczenie z Instytutu Onkologii Uniwersytetu w Stambule i obecnie pełni funkcję profesora nadzwyczajnego w szpitalu Medipol Bahçelievler.

• Specjalizuje się w leczeniu raka wątroby ze szczególnym uwzględnieniem zaawansowanych stadiów
• Posiada certyfikat ESMO w dziedzinie onkologii klinicznej
• Współpracował przy ośmiu międzynarodowych badaniach klinicznych w onkologii
• Opublikował liczne prace naukowe na temat nowotworów z przerzutami

Dr Kopchak specjalizuje się w raku wątroby, łącząc praktykę kliniczną z wiodącymi badaniami w Narodowym Instytucie Raka.

• Ponad 30 artykułów naukowych opublikowanych w czasopismach indeksowanych w Scopus
• Współautor ponad 170 prac badawczych i 2 monografii
• Starszy pracownik naukowy w czołowym ukraińskim instytucie chirurgicznym
• Koncentruje się na strategiach diagnostycznych i chirurgicznych

Z ponad _doctor_2687_letnim_ doświadczeniem chirurgicznym, doc. dr Ugur Ekici specjalizuje się w zaawansowanej chirurgii laparoskopowej i onkologicznej w szpitalu Medicana Bahcelievler.

• Szkolenie specjalizacyjne w Klinice Chirurgii Ogólnej Szpitala Şişli Etfal
• Doświadczenie zarówno w standardowych, jak i małoinwazyjnych zabiegach onkologicznych
• Publikacje naukowe w międzynarodowych czasopismach medycznych

Prof. Ersin Ozturk wnosi ogromne doświadczenie w chirurgii onkologicznej i chirurgii przewodu pokarmowego w szpitalu Medicana Bursa.

• Profesor medycyny z ponad 28 lat doświadczenia doświadczeniem
• Specjalizuje się w chirurgii laparoskopowej i bariatrycznej
• Stypendium badawcze w Cleveland Clinic Foundation
• Członek wielu towarzystw chirurgicznych

Prof. Engin wnosi dziesięciolecia specjalistycznej wiedzy z zakresu onkologii radiacyjnej, w tym zaawansowane szkolenie w National Cancer Institute oraz Thomas Jefferson University.

• Były kierownik Katedry Onkologii Radiacyjnej na Uniwersytecie Uludag
• Kierował programami onkologii radiacyjnej w wielu wiodących szpitalach
• Specjalizuje się w technikach termoradioterapii
• Stypendysta badawczy National Cancer Institute

Dr Sridhar P.S. specjalizuje się w radioterapii raka wątroby w HCG Manavata Cancer Centre, posiadając szerokie przeszkolenie w dziedzinie onkologii.

• Ponad _doctor_3397_ lat doświadczenia w radioterapii
• Dyplomowany członek Krajowej Rady Radioterapii
• Członek Indyjskiego Stowarzyszenia Onkologii Radiacyjnej
• Specjalizuje się w neuroonkologii i onkologii hipertermicznej